SecBot SecBot
SECBOTREPLAY Home › Report › PTGX

PTGX · CEO Dinesh Patel filed a Form 144 notice of intent to sell 225,000…

Protagonist Therapeutics, Inc · 144 filed Aug 10, 2026 at 16:49 ET

At the news

BEARISHIMPACT 5/10

144 filed Aug 10, 2026 at 16:49 ET

CEO Dinesh Patel filed a Form 144 notice of intent to sell 225,000 shares of Protagonist Therapeutics (PTGX) through J.P. Morgan Securities, with an estimated aggregate market value of approximately $33.6 million based on the filing date. This represents a large proposed sale relative to Patel's remaining holdings of ~64.7 million shares, but the CEO's intent to sell a meaningful stake signals potential insider distribution at a $9.4B market cap company.

  • CEO Dinesh Patel filed Form 144 to sell 225,000 shares of PTGX common stock.
  • Estimated aggregate market value of the proposed sale is $33,583,500.
  • Patel holds approximately 64,708,285 shares after the proposed sale (post-sale holdings).
  • The shares to be sold were acquired via option exercise on August 10, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access